S. Salvi (Pune (Maharashtra), India), N. Kahn (Heidelberg, Germany)
Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany
A. Kuhlmann (Hanover, Germany), J. Graf Von Der Schulenburg (Hanover, Germany)
|     |
Cost-effectiveness of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
E. Resta (Foggia, Italy), G. Carpagnano (Bari, Italy), C. Pelaia (Catanzaro, Italy), M. D'Amato (Napoli, Italy), N. Crimi (Catania, Italy), N. Scichilone (Palermo, Italy), C. Calabrese (Napoli, Italy), O. Resta (Bari, Italy), G. Scioscia (Foggia, Italy), G. Pelaia (Catanzaro, Italy), M. Foschino Barbaro (Foggia, Italy)
| |
Management-related costs of Idiopathic Pulmonary Fibrosis (IPF) in Belgium
D. Strens (Leuven, Belgium), B. Bondue (Brussels, Belgium), C. Dahlqvist (Yvoir, Belgium), H. Slabbynk (Antwerpen, Belgium), J. Guiot (Liege, Belgium), G. Joos (Liege, Belgium), N. Gusbin (Liege, Belgium), W. Janssens (Brussels, Belgium), A. Froidure (Brussels, Belgium), W. Wuyts (Leuven, Belgium)
| |
Cost-IPFfectiveness of antifibrotic treatment: real-life data from a Greek University Hospital
I. Dimeas (Larissa, Greece), S. Sinis (Larissa, Greece), P. Kirgou (Larissa, Greece), L. Ioannis (Larissa, Greece), F. Malli (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), Z. Daniil (Larissa, Greece)
| |
Home vs inpatient CPAP titration costs in OSA patients from Southern Italy: the role of telemedicine.
R. Sabato (Foggia, Italy), V. Di Lecce (Bari, Italy), O. Resta (Bari, Italy), G. Carpagnano (Bari, Italy), A. Portacci (Bari, Italy), P. Tondo (Foggia, Italy), D. Lacedonia (Foggia, Italy), M. Foschino Barbaro (Foggia, Italy)
| |
Investigating the Respiratory therapist perception of committed medical incidents in Intensive care unit (ICU).
A. AlQahtani (Nottingham, United Kingdom)
| |
Estimating the Cost of Pulmonary Embolism in Greece with the help of large data
I. Lampropoulos (Larissa, Greece), I. Dimeas (Larissa, Greece), D. Raptis (Larissa, Greece), F. Malli (Larissa, Greece), E. Aggelopoulos (Patras, Greece), Z. Daniil (Larissa, Greece), K. Gourgoulianis (Larissa, Greece)
| |
Publication rate and characteristics of industry-sponsored asthma clinical trials
S. Khanolkar (Airoli, India), R. Thale (Airoli, India), M. Bolshete (Airoli, India), V. Jakhetia (Airoli, India), P. Bolshete (Airoli, India)
| |
The cost of treatment of tuberculosis in children of Belarus
L. Gorbach (Minsk, Belarus)
| |
COPD and Asthma Disease-specific Health-related Quality of Life Scales and Their Applications in Health Technology Assessment and in China: Literature Review
S. Gong (Beijing , China), H. Hu (Beijing , China), Y. Zhang (Beijing , China), F. Xie (Hamilton, Canada), T. Yang (Beijing , China)
| |